Technical analysis of Braskem S.A. ADR (BAK) stock chart patterns

While Braskem S.A. ADR has overperformed by 0.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BAK fell by -13.71%, with highs and lows ranging from $12.67 to $6.26, whereas the simple moving average fell by -17.60% in the last 200 days.

On August 29, 2023, UBS Downgraded Braskem S.A. ADR (NYSE: BAK) to Sell.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Analysis of Braskem S.A. ADR (BAK)

A return on investment can be expected regardless of BAK’s performance over the next quarter with the dividend set at $0.03 per share. Further, the quarter-over-quarter decrease in sales is -29.43%, showing a negative trend in the upcoming months.

To gain a thorough understanding of Braskem S.A. ADR’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -72.10% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.03, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

It is also very valuable to look at average volume as an indicator of volatility for a stock, and BAK is recording an average volume of 1.07M. Furthermore, long-term investors anticipate a median target price of $11.67, showing growth from the present price of $7.30, which can serve as yet another indication of whether BAK is worth investing in or should be passed over.

How Do You Analyze Braskem S.A. ADR Shares?

The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As opposed to executive stock, institutional ownership accounts for 3.16% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in BAK shares?

The recent increase in stakes in BAK appears to be a result of several institutional investors and hedge funds increasing their positions. Renaissance Technologies LLC’s position in BAK has increased by 61.66% in the first quarter. The company now owns 868,600 shares of the stock, with a value of $7.66 million, following the purchase of 331,300 additional shares during the last quarter. Millennium Management LLC made another increased to its shares in BAK during the first quarter, upping its stake by 23.93%. During the last quarter, the company picked up 150,892 additional shares for a total stake of worth $6.89 million, bringing number of shares owned by the company to 781,538.

During the first quarter, The Vanguard Group, Inc. added a 33,298 position in BAK. Dimensional Fund Advisors LP sold an additional 25641.0 shares in the last quarter, decreasing its holdings by -4.65%, now holding 0.53 million shares worth $4.64 million. At the end of the first quarter, Optiver US LLC increased its BAK holdings by 16.76% and now holds 0.42 million BAK shares valued at $3.68 million with the added 59916.0 shares during the period. BAK shares are owned by institutional investors to the tune of 3.16% at present.

Related Posts